BIOSGN — Biosergen AB Cashflow Statement
0.000.00%
- SEK25.80m
- SEK24.14m
Annual cashflow statement for Biosergen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | — | SAS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -6.23 | -34.1 | -34.1 | -27.3 |
Non-Cash Items | -0.498 | -0.24 | 0.081 | — |
Other Non-Cash Items | ||||
Changes in Working Capital | 2.14 | -3.43 | 4.61 | -5.49 |
Change in Accounts Receivable | ||||
Change in Accounts Payable | ||||
Change in Other Liabilities | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | -4.58 | -37.7 | -29.4 | -32.8 |
Net Issuance / Retirement of Stock | ||||
Cash from Financing Activities | 0 | 58.8 | 37.1 | 5.3 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -4.58 | 21.1 | 7.68 | -27.5 |